Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of hypertension
Economic impact of hypertension on families
4 evidence topics · 4 sources
Out-of-pocket share of US spending on treatment of hypertension, 2019
| Payer | Share of 2019 spending on treatment of hypertension, % |
|---|---|
| Medicare | “39.9”View highlighted excerpt for this quote |
| Medicaid | “14.3”View highlighted excerpt for this quote |
| Private insurance | “29.3”View highlighted excerpt for this quote |
| Out of pocket | “16.6”View highlighted excerpt for this quote |
Cost-related medication nonadherence among US adults with hypertension: National Health Interview Survey 2017
“Participants with self-reported hypertension from the 2017 National Health Interview Survey were included (n = 7,498).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Overall, 10.7% reported CRMN, 83.6% reported current antihypertensive medication use, and 67.4% reported normal blood pressure within past 12 months. Adjusted percentages of current antihypertensive medication use (88.6% vs. 82.9%, P < 0.001) and self-reported normal blood pressure (69.8% vs. 59.5%, P = 0.002) were higher among those without CRMN compared with those with CRMN.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Financial barriers to medication adherence persist and impact hypertension management.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Cost-related medication nonadherence by age, sex, and insurance status: National Health Interview Survey 2019 to 2022
“This analytical cross-sectional study utilized data from the National Health Interview Survey Sample from 2019 to 2022.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Women aged 18-64 years more likely (adjusted odds ratio (aOR) 1.44; 95% CI 1.18, 1.75) to experience CRN than men. Notably, uninsured individuals in both the 18-64 (aOR 2.21; 95% CI 1.51, 3.25) and ≥ 65 (aOR 5.55; 95% CI 1.36, 22.75) age groups were at increased risk of facing CRN.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“To mitigate CRN, health quality strategies like prescribing generics, connecting patients with assistance programs, and implementing policies to reduce out-of-pocket costs are essential.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Additive copays for multiple medications: patient input
Caregiver time and cost burden in uncontrolled or resistant hypertension
No evidence found.